[{"DeferredCompensationSharebasedArrangementsLiabilityClassifiedNoncurrent_0_Q1_USD":3200000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":15641000.0,"ProfitLoss_1_Q1_USD":-54480000.0,"ProceedsFromStockPlans_1_Q1_USD":1438000.0,"LiabilitiesCurrent_0_Q1_USD":26818000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":688523000.0,"Liabilities_0_Q1_USD":82004000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":14215000.0,"PurchaseCommitmentRemainingMinimumAmountCommitted_0_Q1_USD":5300000.0,"CashEquivalentsAtCarryingValue_0_Q1_USD":122141000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-39230000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":140195000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q1_USD":553000000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":135897000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":12253000.0,"LettersOfCreditOutstandingAmount_0_Q1_USD":4300000.0,"ProceedsFromSaleAndMaturityOfOtherInvestments_1_Q1_USD":120261000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q1_USD":60121000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":357026000.0,"PaymentsToAcquireInvestments_1_Q1_USD":123015000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":1055386000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_1_Q1_USD":303000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":34736000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":4236000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":73714000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":7633000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":66349000.0,"NonoperatingIncomeExpense_1_Q1_USD":3203000.0,"OtherExpenses_1_Q1_USD":58000.0,"ShareBasedCompensation_1_Q1_USD":14215000.0,"RestrictedCashNoncurrent_0_Q1_USD":4299000.0,"ShortTermInvestments_0_Q1_USD":357026000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q1_USD":1438000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":42042000.0,"VariableLeaseCost_1_Q1_USD":210000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":43836000.0,"OperatingLeasePayments_1_Q1_USD":1400000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":51536000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":1807000.0,"OperatingLeaseLiability_0_Q1_USD":53343000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":303000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":14845000.0,"OperatingLeaseCost_1_Q1_USD":1868000.0,"OperatingIncomeLoss_1_Q1_USD":-57683000.0,"OperatingExpenses_1_Q1_USD":57683000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_1_Q1_USD":710000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-450602000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.5,"AmortizationOfIntangibleAssets_1_Q1_USD":151000.0,"StockholdersEquity_0_Q1_USD":606519000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":108963522.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":14215000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":7951000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":8203000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q1_USD":8467000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_0_Q1_USD":4829000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q1_shares":12448841.0,"CommitmentsAndContingencies_0_Q1_USD":null,"IncomeTaxExpenseBenefit_1_Q1_USD":0.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-54480000.0,"AssetsCurrent_0_Q1_USD":504414000.0,"Assets_0_Q1_USD":688523000.0,"Depreciation_1_Q1_USD":1893000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-2552000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_1_Q1_USD":207000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_1_Q1_USD":-701000.0,"IncreaseDecreaseInOtherNoncurrentAssets_1_Q1_USD":57000.0,"AccountsPayableCurrent_0_Q1_USD":7199000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":29182402.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q1_USD":465000.0,"DeferredIncomeTaxExpenseBenefit_1_Q1_USD":0.0,"OtherAssetsNoncurrent_0_Q1_USD":4675000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.0834,"DeferredCompensationShareBasedArrangementsLiabilityCurrent_0_Q1_USD":2800000.0,"PreferredStockValue_0_Q1_USD":0.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"CommonStockSharesAuthorized_0_Q1_shares":200000000.0,"CommonStockSharesIssued_0_Q1_shares":125262537.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q1_USD":55398000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":91888000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":14845000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":0.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":1610000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":537235000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":277000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":2330000.0,"LongTermInvestments_0_Q1_USD":60121000.0,"LeaseCost_1_Q1_USD":2078000.0,"LeaseAndRentalExpense_1_Q1_USD":718000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":3650000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":7365000.0,"NetIncomeLoss_1_Q1_USD":-54480000.0,"PaymentsForLeasingCostsCommissionsAndTenantImprovements_1_Q1_USD":1396000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-40809000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-15007000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":16586000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-54015000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1_Q1_USD":-3913000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-1044000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":11491000.0,"CommonStockValue_0_Q1_USD":125000.0,"CommonStockSharesOutstanding_0_Q1_shares":125262537.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":4208000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":3261000.0,"Ticker":"ALLO","CIK":"1737287","name":"ALLOGENE THERAPEUTICS, INC.","OfficialName":"Allogene Therapeutics Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1134878416.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20200506"}]